Showing results (141-150 of 148) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Gynecologic Oncology Reports|April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinomaElizabeth H Stover, Niya Xiong, Andrea P Myers, et al.Journal of the American College of Radiology : JACR|November 5, 2013
ACR appropriateness criteria staging and follow-up of ovarian cancerDonald G Mitchell, Marcia C Javitt, Phyllis Glanc, et al.JCO Precision Oncology|April 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial CancerPanagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypesYassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2020
Correction: Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypesYassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.Cancer Discovery|September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer OrganoidsSarah J Hill, Brennan Decker, Emma A Roberts, et al.Cancer Research|November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian CancerChangxin Wan, Matthew P Keany, Han Dong, et al.Cancers|July 2, 2021
Dissection of PIK3CA Aberration for Cervical Adenocarcinoma OutcomesTony K H Chung, Graeme Doran, Tak-Hong Cheung, et al.Pageof 15